Responses to Sars-Cov-2 Vaccines in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

Introduction: Patients with myeloid malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), are at a high risk of severe SARS-CoV-2 infection. It is uncertain whether patients with AML and MDS, who frequently have quantitative or qualitative deficiencies of neutrophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Akriti G, Dong, Ning C., Ball, Somedeb, Tan, Elaine S, Whiting, Junmin, Komrokji, Rami S., Sweet, Kendra, Chan, Onyee, Sallman, David A., Padron, Eric, Kuykendall, Andrew T., Giuliano, Anna, Lancet, Jeffrey E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
613.Acute Myeloid Leukemias: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701522/
http://dx.doi.org/10.1182/blood-2021-151669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701522/
http://dx.doi.org/10.1182/blood-2021-151669

Ejemplares similares